563 related articles for article (PubMed ID: 17113075)
1. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
2. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
Liechti ME; Markou A
Biochem Pharmacol; 2007 Oct; 74(8):1299-307. PubMed ID: 17601493
[TBL] [Abstract][Full Text] [Related]
4. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
[TBL] [Abstract][Full Text] [Related]
6. The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat.
van der Kam EL; De Vry J; Tzschentke TM
Eur J Pharmacol; 2009 Apr; 607(1-3):114-20. PubMed ID: 19326478
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
D'Souza MS; Markou A
Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
[TBL] [Abstract][Full Text] [Related]
8. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
Paterson NE; Semenova S; Gasparini F; Markou A
Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
[TBL] [Abstract][Full Text] [Related]
9. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
Rasmussen K; Hsu MA; Vandergriff J
Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats.
Kenny PJ; Boutrel B; Gasparini F; Koob GF; Markou A
Psychopharmacology (Berl); 2005 Apr; 179(1):247-54. PubMed ID: 15602687
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
[TBL] [Abstract][Full Text] [Related]
12. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
Harrison AA; Gasparini F; Markou A
Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
[TBL] [Abstract][Full Text] [Related]
13. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.
Paterson NE; Markou A
Psychopharmacology (Berl); 2005 Apr; 179(1):255-61. PubMed ID: 15619120
[TBL] [Abstract][Full Text] [Related]
14. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
Stoker AK; Olivier B; Markou A
Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
[TBL] [Abstract][Full Text] [Related]
15. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
16. The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task.
Semenova S; Markou A
Neuropharmacology; 2007 Mar; 52(3):863-72. PubMed ID: 17126859
[TBL] [Abstract][Full Text] [Related]
17. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
18. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
19. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
20. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.
Tronci V; Balfour DJ
Behav Brain Res; 2011 Jun; 219(2):354-7. PubMed ID: 21216262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
